ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia

Stopped The treatment planned was determined to be of low feasibility as no subject was found eligible and able to enroll after screening over 30 subjects

Conditions

• Acute Myeloid Leukemia

Interventions

• DRUG: G-CSF
• DRUG: Cytarabine
• DRUG: Fludarabine
• BIOLOGICAL: Donor Natural Killer (NK) cells
• BIOLOGICAL: ALT-801

Sponsor

Altor BioScience

Collaborators

• [object Object]